Literature Review of Current Management of Colorectal Liver Metastasis
- PMID: 30937238
- PMCID: PMC6433446
- DOI: 10.7759/cureus.3940
Literature Review of Current Management of Colorectal Liver Metastasis
Abstract
Colorectal cancer is a leading cause of cancer mortality in the United States, and metastasis to the liver is a frequent sequela. Currently, surgical resection is the best option for curative treatment and/or long-term survival after colorectal liver metastasis (CRLM), but unfortunately, not all patients are surgical candidates. Alternative and adjunct therapies commonly used in the treatment of CRLM include chemotherapy, biologic therapy, radio-embolization, and radiofrequency ablation. The aim of this review was to report the various treatment modalities and outcomes currently used in the treatment of CRLM.
Keywords: chemotherapy; colorectal cancer; intra-arterial chemotherapy; liver metastasis; management; radiofrequency ablation; surgery.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide. [Sep;2017 ];http://globocan.iarc.fr/Pages/fact_sheets_population.aspx 2012
-
- Cameron J, Cameron A. Philadelphia: Elsevier Health Sciences; 2016. Current Surgical Therapy E-Book 12th Edition.
-
- Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases: a systematic review. Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Eur J Cancer. 2012;48:1757–1765. - PubMed
Publication types
LinkOut - more resources
Full Text Sources